New drug trial for kids with severe psoriasis shows promise
NCT ID NCT03240809
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 32 times
Summary
This study tests a single dose of brodalumab in children aged 6 to 17 with severe plaque psoriasis. The goal is to check safety and how the drug works in the body. Only 2 children are enrolled, so results are very early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bausch Site 001
Las Vegas, Nevada, 45242, United States
-
Bausch Site 002
Miami, Florida, 33155, United States
-
Bausch Site 003
San Diego, California, 92123, United States
-
Bausch Site 004
Miami, Florida, 33155, United States
-
Bausch Site 005
Henderson, Nevada, 89052, United States
Conditions
Explore the condition pages connected to this study.